chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in jaw, Sinusitis, Somnolence, Vaccination complication
Clinical narrative: Feels like it is a migraine or sinus infection; Feels like it is a migraine or sinus infection; indigestion; Feels like her jaw hurts, into her ears and into back of her neck; Woke up feeling tired; Arm hurts a little; Woke up feeling groggy; sore throat; Started to feel worse; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Feels like it is a migraine or sinus infection), SINUSITIS (Feels like it is a migraine or sinus infection), DYSPEPSIA (indigestion), PAIN IN JAW (Feels like her jaw hurts, into her ears and into back of her neck) and FATIGUE (Woke up feeling tired) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA), VITAMIN D NOS, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and EPIDURAL INJECTION for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced MIGRAINE (Feels like it is a migraine or sinus infection), SINUSITIS (Feels like it is a migraine or sinus infection), DYSPEPSIA (indigestion), PAIN IN JAW (Feels like her jaw hurts, into her ears and into back of her neck), FATIGUE (Woke up feeling tired), PAIN IN EXTREMITY (Arm hurts a little), SOMNOLENCE (Woke up feeling groggy), OROPHARYNGEAL PAIN (sore throat) and VACCINATION COMPLICATION (Started to feel worse). At the time of the report, MIGRAINE (Feels like it is a migraine or sinus infection), SINUSITIS (Feels like it is a migraine or sinus infection), DYSPEPSIA (indigestion), PAIN IN JAW (Feels like her jaw hurts, into her ears and into back of her neck), FATIGUE (Woke up feeling tired), PAIN IN EXTREMITY (Arm hurts a little), SOMNOLENCE (Woke up feeling groggy), OROPHARYNGEAL PAIN (sore throat) and VACCINATION COMPLICATION (Started to feel worse) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had epidural injection three weeks prior to vaccine. Treatment information includes  Ibuprofen  ,  Bayer migraine medicine and didn't help and Tylenol for Sinus but  it hadn't helped.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Pain in arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010421A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue). On 07-Mar-2021, PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication was not provided Treatment information was not provided   This case was linked to MOD-2021-207658 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Significant follow-up added. 2nd dose information were added.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Fatigue, Migraine, Palpitations
Clinical narrative: Racing heartbeat; severe stomach cramps; diarrhea; migraine headache; violent vomiting; Fever, aches and chills; Fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (severe stomach cramps), DIARRHOEA (diarrhea), MIGRAINE (migraine headache), PALPITATIONS (Racing heartbeat) and FATIGUE (Fatigue) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included SILICON DIOXIDE (VIVISCAL [SILICON DIOXIDE]) for Biotin supplementation, ASCORBIC ACID (VIT C), COLECALCIFEROL (VIT D [COLECALCIFEROL]), ZINC and BIOTIN for an unknown indication.    On 07-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced FATIGUE (Fatigue) and VACCINATION SITE PAIN (sore arm). On 08-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (severe stomach cramps), DIARRHOEA (diarrhea), MIGRAINE (migraine headache), VOMITING (violent vomiting) and PYREXIA (Fever, aches and chills). On 08-Mar-2021 at 10:00 AM, the patient experienced PALPITATIONS (Racing heartbeat). On 08-Mar-2021, FATIGUE (Fatigue) and VACCINATION SITE PAIN (sore arm) had resolved. On 09-Mar-2021, ABDOMINAL PAIN UPPER (severe stomach cramps), DIARRHOEA (diarrhea), MIGRAINE (migraine headache), VOMITING (violent vomiting) and PYREXIA (Fever, aches and chills) had resolved. At the time of the report, PALPITATIONS (Racing heartbeat) had resolved with sequelae.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       The patient had developed severe stomach cramps and a migrane headache. This turned into severe vomiting and diarrhea to the point where couldn't even keep water down. The patient also had a racing heartbeat. Then developed fever and aches and chills. No treatment medications were reported   This case was linked to MOD-2021-267071 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Upon follow-up received:Updated patient demographics, allergic condition, suspect drug administration time, added concomitant medication, and added new event heart racing.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Racing heartbeat; severe stomach cramps; diarrhea; migraine headache; violent vomiting; Fever, aches and chills; Fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (severe stomach cramps), DIARRHOEA (diarrhea), MIGRAINE (migraine headache), PALPITATIONS (Racing heartbeat) and FATIGUE (Fatigue) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included SILICON DIOXIDE (VIVISCAL [SILICON DIOXIDE]) for Biotin supplementation, ASCORBIC ACID (VIT C), COLECALCIFEROL (VIT D [COLECALCIFEROL]), ZINC and BIOTIN for an unknown indication.    On 07-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced FATIGUE (Fatigue) and VACCINATION SITE PAIN (sore arm). On 08-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (severe stomach cramps), DIARRHOEA (diarrhea), MIGRAINE (migraine headache), VOMITING (violent vomiting) and PYREXIA (Fever, aches and chills). On 08-Mar-2021 at 10:00 AM, the patient experienced PALPITATIONS (Racing heartbeat). On 08-Mar-2021, FATIGUE (Fatigue) and VACCINATION SITE PAIN (sore arm) had resolved. On 09-Mar-2021, ABDOMINAL PAIN UPPER (severe stomach cramps), DIARRHOEA (diarrhea), MIGRAINE (migraine headache), VOMITING (violent vomiting) and PYREXIA (Fever, aches and chills) had resolved. At the time of the report, PALPITATIONS (Racing heartbeat) had resolved with sequelae.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       The patient had developed severe stomach cramps and a migrane headache. This turned into severe vomiting and diarrhea to the point where couldn't even keep water down. The patient also had a racing heartbeat. Then developed fever and aches and chills. No treatment medications were reported   This case was linked to MOD-2021-267071 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Upon follow-up received:Updated patient demographics, allergic condition, suspect drug administration time, added concomitant medication, and added new event heart racing.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain and injection site nodule (a lump near her arm at the injection) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 26, 2021, patient experienced pain and injection site nodule (a lump near her arm at the injection). At the time of the report, pain and injection site nodule (a lump near her arm at the injection) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided. Sender's comments: Case linked to MOD-2021-059945 (E2B linked report): Father case.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Covid +ve; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid +ve) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced COVID-19 (Covid +ve). On 22-Mar-2021, COVID-19 (Covid +ve) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Muscular weakness, Myalgia
Clinical narrative: Could not get out of bed without falling down; Muscle weakness in legs; Muscle pain in legs; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Could not get out of bed without falling down) and MUSCULAR WEAKNESS (Muscle weakness in legs) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced FALL (Could not get out of bed without falling down) and MUSCULAR WEAKNESS (Muscle weakness in legs). At the time of the report, FALL (Could not get out of bed without falling down) and MUSCULAR WEAKNESS (Muscle weakness in legs) was resolving.  Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: TCR NNI
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Slight Fever; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight Fever) and PAIN IN EXTREMITY (Sore Arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Shingles in 2020.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PYREXIA (Slight Fever) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, PYREXIA (Slight Fever) and PAIN IN EXTREMITY (Sore Arm) had resolved.            This case was linked to US-MODERNATX, INC.-MOD-2021-059855 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-059855:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cystitis, Diarrhoea, Pain in extremity, Sleep deficit
Clinical narrative: Feels like Bladder Infection; Nap for 4.5 hours; Diarrhea; Arm hurt; had Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Arm hurt), CHILLS (had Chills), CYSTITIS (Feels like Bladder Infection) and SLEEP DEFICIT (Nap for 4.5 hours) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Bladder infection. Concomitant products included CIPROFLOXACIN (CIPRO [CIPROFLOXACIN]) for Bladder infection.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Arm hurt), CHILLS (had Chills) and SLEEP DEFICIT (Nap for 4.5 hours). On 24-Mar-2021, the patient experienced CYSTITIS (Feels like Bladder Infection). On 03-Mar-2021, DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Arm hurt), CHILLS (had Chills) and SLEEP DEFICIT (Nap for 4.5 hours) had resolved. At the time of the report, CYSTITIS (Feels like Bladder Infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Paraesthesia, Periorbital swelling
Clinical narrative: swollen under her left eye; tingling sensation; cold; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation), NASOPHARYNGITIS (cold) and PERIORBITAL SWELLING (swollen under her left eye) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL SUCCINATE (TOPROL) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PARAESTHESIA (tingling sensation) and NASOPHARYNGITIS (cold). On 25-Mar-2021, the patient experienced PERIORBITAL SWELLING (swollen under her left eye). On 24-Mar-2021, PARAESTHESIA (tingling sensation) and NASOPHARYNGITIS (cold) had resolved. At the time of the report, PERIORBITAL SWELLING (swollen under her left eye) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site rash
Clinical narrative: red, hard itchy, spot on the injection site; red, hard itchy, spot on the injection site; red spot on the injection site; red spot on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (red, hard itchy, spot on the injection site), VACCINATION SITE PRURITUS (red, hard itchy, spot on the injection site), VACCINATION SITE ERYTHEMA (red spot on the injection site) and VACCINATION SITE RASH (red spot on the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concomitant products included ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]), SERTRALINE, VITAMINS NOS, TOPIRAMATE, TIOTIXENE HYDROCHLORIDE (THIOTHIXENE [TIOTIXENE HYDROCHLORIDE]) and SIMVASTATIN for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE INDURATION (red, hard itchy, spot on the injection site), VACCINATION SITE PRURITUS (red, hard itchy, spot on the injection site), VACCINATION SITE ERYTHEMA (red spot on the injection site) and VACCINATION SITE RASH (red spot on the injection site). At the time of the report, VACCINATION SITE INDURATION (red, hard itchy, spot on the injection site), VACCINATION SITE PRURITUS (red, hard itchy, spot on the injection site), VACCINATION SITE ERYTHEMA (red spot on the injection site) and VACCINATION SITE RASH (red spot on the injection site) had resolved.            The patient confirmed that she had no problems with the second dose.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up received included the suspect product dosage regimen was updated. On 22-Jul-2021: Follow up received included Outcome of the events were updated.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Covid-19 Virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Covid-19 Virus test positive) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Covid-19 Virus test positive). At the time of the report, SARS-COV-2 TEST POSITIVE (Covid-19 Virus test positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Fall
Clinical narrative: Took a fall; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Took a fall) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 26-Mar-2021, the patient experienced FALL (Took a fall). At the time of the report, FALL (Took a fall) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pruritus
Clinical narrative: red  knot at the site of injection; itchy knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (red  knot at the site of injection) and VACCINATION SITE PRURITUS (itchy knot at the site of injection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE MASS (red  knot at the site of injection) and VACCINATION SITE PRURITUS (itchy knot at the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE (topical) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (red  knot at the site of injection) and VACCINATION SITE PRURITUS (itchy knot at the site of injection) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration
Clinical narrative: developed Covid-19; late second dose; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of COVID-19 (developed Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (late second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     The patient's past medical history included No adverse event (No medical history was reported.).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (developed Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (late second dose). At the time of the report, COVID-19 (developed Covid-19) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (late second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   MD was unsure if the patient received monoclonal antibodies or convalescent plasma. She knows the CDC recommends up to 42 days to give the second dose.   Reporter did not allow further contact
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 628A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VOMITING (Vomiting). At the time of the report, VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-063305 (E2B Linked Report).; Sender's Comments:  MOD21-063305:
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Diarrhoea, Fatigue, Headache, Limb discomfort
Clinical narrative: arm is sore; can't lift arm; achy; fatigue; throwing up not keeping any food down; diarrhea; cold sweat; headache; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (throwing up not keeping any food down), DIARRHOEA (diarrhea), COLD SWEAT (cold sweat), HEADACHE (headache) and PAIN IN EXTREMITY (arm is sore) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included Diabetes.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced VOMITING (throwing up not keeping any food down), DIARRHOEA (diarrhea), COLD SWEAT (cold sweat) and HEADACHE (headache). On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't lift arm), PAIN (achy) and FATIGUE (fatigue). On 26-Mar-2021, VOMITING (throwing up not keeping any food down), DIARRHOEA (diarrhea), COLD SWEAT (cold sweat) and HEADACHE (headache) had resolved. At the time of the report, PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't lift arm), PAIN (achy) and FATIGUE (fatigue) outcome was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vomiting
Clinical narrative: arm is sore; can't lift arm; achy; fatigue; throwing up not keeping any food down; diarrhea; cold sweat; headache; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (throwing up not keeping any food down), DIARRHOEA (diarrhea), COLD SWEAT (cold sweat), HEADACHE (headache) and PAIN IN EXTREMITY (arm is sore) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included Diabetes.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced VOMITING (throwing up not keeping any food down), DIARRHOEA (diarrhea), COLD SWEAT (cold sweat) and HEADACHE (headache). On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't lift arm), PAIN (achy) and FATIGUE (fatigue). On 26-Mar-2021, VOMITING (throwing up not keeping any food down), DIARRHOEA (diarrhea), COLD SWEAT (cold sweat) and HEADACHE (headache) had resolved. At the time of the report, PAIN IN EXTREMITY (arm is sore), LIMB DISCOMFORT (can't lift arm), PAIN (achy) and FATIGUE (fatigue) outcome was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Muscle spasms
Clinical narrative: Diarrhea; Cramping; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and MUSCLE SPASMS (Cramping) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). 22-Mar-2021, the patient experienced MUSCLE SPASMS (Cramping). On 25-Mar-2021, DIARRHOEA (Diarrhea) was resolving. At the time of the report, MUSCLE SPASMS (Cramping) was resolving.            The patient received Imodium AD as treatment drug. The action taken for the second dose of Moderna COVID-19 vaccine is not applicable.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore Arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included BP Pills for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information included Tylenol, Ibuprofen and concomitant drugs
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Pyrexia, Vaccination site pain
Clinical narrative: sore arm (after the second dose); diarrhea (after the second dose); Feeling with no energy (after the second dose); Fever (after the second dose); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm (after the second dose)), DIARRHOEA (diarrhea (after the second dose)), ASTHENIA (Feeling with no energy (after the second dose)) and PYREXIA (Fever (after the second dose)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Redness on 24-Feb-2021.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm (after the second dose)), DIARRHOEA (diarrhea (after the second dose)), ASTHENIA (Feeling with no energy (after the second dose)) and PYREXIA (Fever (after the second dose)). At the time of the report, VACCINATION SITE PAIN (sore arm (after the second dose)), DIARRHOEA (diarrhea (after the second dose)), ASTHENIA (Feeling with no energy (after the second dose)) and PYREXIA (Fever (after the second dose)) outcome was unknown. Not Provided          Concomitant medication was not provided Treatment information was not provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable    This case was linked to INC.-MOD-2021-059947 (E2B Linked Report).; Sender's Comments: INC.-MOD-2021-059947:Case for first dose
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Vaccination site erythema, Vaccination site nodule, Vaccination site pain
Clinical narrative: "It looks like Covid arm"; body aches; hot to touch; a 2-inch diam raised red bump at injection site; muscle aches; tender; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site) and MYALGIA (muscle aches) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arrhythmia (Patient's past medical history includes Abnormal heart rhythm.). Concurrent medical conditions included Hypertension.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site), MYALGIA (muscle aches), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site), MYALGIA (muscle aches), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (red) had resolved.            No concomitant medication and Treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Outcome of events were updated.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction, Vaccination site warmth
Clinical narrative: "It looks like Covid arm"; body aches; hot to touch; a 2-inch diam raised red bump at injection site; muscle aches; tender; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site) and MYALGIA (muscle aches) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arrhythmia (Patient's past medical history includes Abnormal heart rhythm.). Concurrent medical conditions included Hypertension.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site), MYALGIA (muscle aches), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE REACTION ("It looks like Covid arm"), PAIN (body aches), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE NODULE (a 2-inch diam raised red bump at injection site), MYALGIA (muscle aches), VACCINATION SITE PAIN (tender) and VACCINATION SITE ERYTHEMA (red) had resolved.            No concomitant medication and Treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Outcome of events were updated.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Feeling abnormal, Rhinorrhoea
Clinical narrative: Feeling bad; Sniffles; Loss of appetite; Chilled to the bone; Fatigue; Patient test positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad), RHINORRHOEA (Sniffles), DECREASED APPETITE (Loss of appetite), CHILLS (Chilled to the bone) and FATIGUE (Fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling bad), RHINORRHOEA (Sniffles), DECREASED APPETITE (Loss of appetite), CHILLS (Chilled to the bone), FATIGUE (Fatigue) and SARS-COV-2 ANTIBODY TEST POSITIVE (Patient test positive for COVID-19). On 10-Mar-2021, RHINORRHOEA (Sniffles), DECREASED APPETITE (Loss of appetite) and FATIGUE (Fatigue) had resolved, CHILLS (Chilled to the bone) outcome was unknown. At the time of the report, FEELING ABNORMAL (Feeling bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test positive, SARS-CoV-2 test positive
Clinical narrative: Feeling bad; Sniffles; Loss of appetite; Chilled to the bone; Fatigue; Patient test positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad), RHINORRHOEA (Sniffles), DECREASED APPETITE (Loss of appetite), CHILLS (Chilled to the bone) and FATIGUE (Fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling bad), RHINORRHOEA (Sniffles), DECREASED APPETITE (Loss of appetite), CHILLS (Chilled to the bone), FATIGUE (Fatigue) and SARS-COV-2 ANTIBODY TEST POSITIVE (Patient test positive for COVID-19). On 10-Mar-2021, RHINORRHOEA (Sniffles), DECREASED APPETITE (Loss of appetite) and FATIGUE (Fatigue) had resolved, CHILLS (Chilled to the bone) outcome was unknown. At the time of the report, FEELING ABNORMAL (Feeling bad) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Hot flush, Pruritus, Tremor
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of tremors, pruritus (face very itchy), erythema (face red), hot flush (face flushed) and chills in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced tremors, pruritus (face very itchy), erythema (face red), hot flush (face flushed) and chills. The patient treated with hydrocortisone at an unspecified dose and frequency. At the time of the report, tremors, pruritus (face very itchy), erythema (face red), hot flush (face flushed) and chills outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The patient applied ice on her face. No concomitant medications reported.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: menstrual bleeding started earlier and is still bleeding; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (menstrual bleeding started earlier and is still bleeding) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Pre-diabetic. Concomitant products included METFORMIN for Pre-diabetic.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (menstrual bleeding started earlier and is still bleeding). At the time of the report, HEAVY MENSTRUAL BLEEDING (menstrual bleeding started earlier and is still bleeding) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pain. At the time of the report, pain outcome: unknown/not provided The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Sender's comments: This case linked to MOD-2021-059921 (E2B linked report): Daughter case.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: swollen at the injection site; bumpy at the injection site; itchy at the injection site; red at the injection site; Rough at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE MASS (bumpy at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE REACTION (Rough at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 31630A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE MASS (bumpy at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE REACTION (Rough at the injection site). At the time of the report, VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE MASS (bumpy at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE REACTION (Rough at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO concomitant medications was included. no treatment details was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Red mark (after the first dose); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red mark (after the first dose)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-Mar-2021, the patient experienced ERYTHEMA (Red mark (after the first dose)). At the time of the report, ERYTHEMA (Red mark (after the first dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications are not provided. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-059938 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-059938:Case for second dose
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pruritus, Urticaria
Clinical narrative: uncomfortable itchy feeling; chills; body aches; overall itchiness; Headache; hives; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (body aches), PRURITUS (overall itchiness/ uncomfortable itchy feeling), HEADACHE (Headache) and URTICARIA (hives) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Seasonal allergy, Drug allergy (allergy to Levofloxacin) and Drug allergy (allergy to  Keflex).    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced URTICARIA (hives). On 17-Mar-2021, the patient experienced CHILLS (chills), MYALGIA (body aches), PRURITUS (overall itchiness/ uncomfortable itchy feeling) and HEADACHE (Headache). On 19-Mar-2021, URTICARIA (hives) had resolved. At the time of the report, CHILLS (chills), MYALGIA (body aches), PRURITUS (overall itchiness/ uncomfortable itchy feeling) and HEADACHE (Headache) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Diarrhoea, Fatigue, Gastrooesophageal reflux disease
Clinical narrative: after the second shot I was very very sick/symptoms after the second vaccine hung on for a while; Fatigue; high fever; headache; Chills; Body ache; Severe Nausea; Diarrhea; stomach is just not right; heart burn and acid reflux; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (stomach is just not right), GASTROOESOPHAGEAL REFLUX DISEASE (heart burn and acid reflux), ILLNESS (after the second shot I was very very sick/symptoms after the second vaccine hung on for a while) and FATIGUE (Fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL DISCOMFORT (stomach is just not right), GASTROOESOPHAGEAL REFLUX DISEASE (heart burn and acid reflux), FATIGUE (Fatigue), PYREXIA (high fever), HEADACHE (headache), CHILLS (Chills), MYALGIA (Body ache) and NAUSEA (Severe Nausea). On an unknown date, the patient experienced ILLNESS (after the second shot I was very very sick/symptoms after the second vaccine hung on for a while). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) at an unspecified dose and frequency and CALCIUM CARBONATE, MAGNESIUM HYDROXIDE (ROLAIDS [CALCIUM CARBONATE;MAGNESIUM HYDROXIDE]) at an unspecified dose and frequency. On 11-Mar-2021, PYREXIA (high fever) had resolved. On 12-Mar-2021, DIARRHOEA (Diarrhea), CHILLS (Chills), MYALGIA (Body ache) and NAUSEA (Severe Nausea) had resolved. On 15-Mar-2021, FATIGUE (Fatigue) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (stomach is just not right), GASTROOESOPHAGEAL REFLUX DISEASE (heart burn and acid reflux) and HEADACHE (headache) had not resolved and ILLNESS (after the second shot I was very very sick/symptoms after the second vaccine hung on for a while) outcome was unknown.            No concomitant medications were reported.   Action taken with mRNA-1273 in response to the event was not applicable.          This case was linked to MOD-2021-059889 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 12-May-2021, contains non-significant information.; Sender's Comments:  MOD-2021-059889:First Dose of Vaccine case for same patient.